Anyone have a DD starter to catch me up. Where are they at with bertilimumab, nanocyclo, ceplene......
Haven’t been following for 2 years but can’t believe it’s this cheap even with just the orphan drug designation for BP. Glad they fired that crook Teper, and another one since lol.
Thinking of catching this knife cause bertilimumab has huge potential. Thanks to past shareholders for funding the trials/delays/salaries......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.